Two GV partners on biotech's reset and building their next drug startups
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Krishna Yeshwant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Some of the top gene-editing stocks have had immense surge potential. Look at CRISPR Therapeutics, for example.
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.
The greater Boston area claims a number of savvy, if under-the-radar, investors as residents. We asked VCs about the ones to know.
The Boston-based biotech will work on new "small molecule" drugs to combat cancer and other ailments.